J&J�s Drug for Chronic Pain Receives FDA Approval
The US Food and Drug Administration revealed that it has approved Johnson&Johnson’s tapentadol extended release drug, Nucynta ER
The US Food and Drug Administration revealed that it has approved Johnson&Johnson’s tapentadol extended release drug, Nucynta ER
Source-Medindia
Chronic Pain Management Set to Get Better
Pain care management needs to be improved, with health care professionals committing to improve care as well as a retooling of the health care system to help people who are suffering,
Pain care management needs to be improved, with health care professionals committing to improve care as well as a retooling of the health care system to help people who are suffering,
Chronic Pain More for Smokers Than Non-smokers
Smokers are more likely to report problems with persistent musculoskeletal pain than non-smokers, a new study has found.
Smokers are more likely to report problems with persistent musculoskeletal pain than non-smokers, a new study has found.
Below Par Management of Chronic Pain in Homeless People
New research by St. Michael's Hospital finds that chronic pain is not managed well in the general population and it's an even greater challenge for homeless people.
New research by St. Michael's Hospital finds that chronic pain is not managed well in the general population and it's an even greater challenge for homeless people.
